Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1978 Mar;5(3):255–260. doi: 10.1111/j.1365-2125.1978.tb01633.x

The effects of intravenous isoxsuprine on blood viscosity in patients with occlusive peripheral arterial disease.

T Di Perri, S Forconi, D Agnusdei, M Guerrini, F Laghi Pasini
PMCID: PMC1429281  PMID: 656271

Abstract

1 Blood viscosity is thought to be a major factor in disorders of the peripheral circulation. 2 Ten patients with obliterative arterial disease received an infusion of isoxsuprine of 20 micrograms kg-1 for 30 min. The infusion was followed by a highly significant and prolonged fall in blood, plasma and serum viscosity, in haematocrit and in plasma fibrinogen concentration. Blood lipid levels were also studied: total lipids and total cholesterol did not alter; triglyceride level was significantly lowered at the end of, and after, drug infusion. 3 There was no change in blood, plasma or serum viscosity in the four patients receiving a control infusion 2 days before the infusion of isoxsuprine. 4 The relationships between lowered viscosity and increasing peripheral tissue perfusion are discussed.

Full text

PDF
256

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. COGAN D. G., MEROLA L., LAIBSON P. R. Blood viscosity, serum hexosamine and diabetic retinopathy. Diabetes. 1961 Sep-Oct;10:393–395. doi: 10.2337/diab.10.5.393. [DOI] [PubMed] [Google Scholar]
  2. DINTENFASS L. SOME OBSERVATIONS ON THE VISCOSITY OF PATHOLOGICAL HUMAN BLOOD PLASMA. Thromb Diath Haemorrh. 1965 Jun 15;13:492–499. [PubMed] [Google Scholar]
  3. DUNCOMBE W. G. THE COLORIMETRIC MICRO-DETERMINATION OF NON-ESTERIFIED FATTY ACIDS IN PLASMA. Clin Chim Acta. 1964 Feb;9:122–125. doi: 10.1016/0009-8981(64)90004-x. [DOI] [PubMed] [Google Scholar]
  4. Dintenfass L. Blood rheology as diagnostic and predictive tool in cardiovascular diseases. Effect of ABO blood groups. Angiology. 1974 Jun;25(6):365–372. doi: 10.1177/000331977402500601. [DOI] [PubMed] [Google Scholar]
  5. Dintenfass L. Influence of ABO blood groups on the selective disaggregation of the red cells caused by drug RA433. Med J Aust. 1970 Oct 31;2(18):827–830. doi: 10.5694/j.1326-5377.1970.tb63208.x. [DOI] [PubMed] [Google Scholar]
  6. Dintenfass L., Julian D. G., Miller G. E. Viscosity of blood in normal subjects and in patients suffering from coronary occlusion and arterial thrombosis. An in vitro study in the absence of anticoagulants, by means of a rotational cone-in-cone trolley viscometer. Am Heart J. 1966 May;71(5):587–600. doi: 10.1016/0002-8703(66)90308-5. [DOI] [PubMed] [Google Scholar]
  7. Dormandy J. A., Hoare E., Colley J., Arrowsmith D. E., Dormandy T. L. Clinical, haemodynamic, rheological, and biochemical findings in 126 patients with intermittent claudication. Br Med J. 1973 Dec 8;4(5892):576–581. doi: 10.1136/bmj.4.5892.576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dormandy J. A., Hoare E., Khattab A. H., Arrowsmith D. E., Dormandy T. L. Prognostic significance of rheological and biochemical findings in patients with intermittent claudication. Br Med J. 1973 Dec 8;4(5892):581–583. doi: 10.1136/bmj.4.5892.581. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dormandy J. A. Letter: Hyperviscosity angina. Lancet. 1975 Mar 22;1(7908):679–680. doi: 10.1016/s0140-6736(75)91779-1. [DOI] [PubMed] [Google Scholar]
  10. Eggstein M. Eine neue Bestimmung der Neutralfette im Blutserum und Gewebe. II. Zuverlässigkeit der Methode, andere Neutralfettbestimmungen, Normalwerte für Triglyceride und Glycerin im menschlichen Blut. Klin Wochenschr. 1966 Mar 1;44(5):267–273. doi: 10.1007/BF01747717. [DOI] [PubMed] [Google Scholar]
  11. Ehrly A. M. Reduction in blood viscosity at low rates of shear by surface active substances: a new hemorheologic phenomenon. Biorheology. 1968 Sep;5(3):209–214. doi: 10.3233/bir-1968-5303. [DOI] [PubMed] [Google Scholar]
  12. Jan K. M., Chien S., Bigger J. T., Jr Observations on blood viscosity changes after acute myocardial infarction. Circulation. 1975 Jun;51(6):1079–1084. doi: 10.1161/01.cir.51.6.1079. [DOI] [PubMed] [Google Scholar]
  13. Lauwerys R. R. Colorimetric determination of free fatty acids. Anal Biochem. 1969 Nov;32(2):331–333. doi: 10.1016/0003-2697(69)90093-1. [DOI] [PubMed] [Google Scholar]
  14. MADOW B. P. Use of antimalarial drugs as "desludging" agents in vascular disease processes. J Am Med Assoc. 1960 Apr 9;172:1630–1633. doi: 10.1001/jama.1960.03020150054010. [DOI] [PubMed] [Google Scholar]
  15. McMillan D. E. Disturbance of serum viscosity in diabetes mellitus. J Clin Invest. 1974 Apr;53(4):1071–1079. doi: 10.1172/JCI107644. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Müller R. [Diabetic angiopathy and blood viscosity (author's transl)]. Acta Diabetol Lat. 1973;10(6):1311–1324. doi: 10.1007/BF02590717. [DOI] [PubMed] [Google Scholar]
  17. Skovborg F., Nielsen A. V., Schlichtkrull J., Ditzel J. Blood-viscosity in diabetic patients. Lancet. 1966 Jan 15;1(7429):129–131. doi: 10.1016/s0140-6736(66)91264-5. [DOI] [PubMed] [Google Scholar]
  18. Stewart J. S., Mostert J. W., Hilton D. D., McGrath D. Bicarbonate therapy during embolectomy. Prevention of acidosis shock and acidosis arrest. Lancet. 1965 Dec 25;2(7426):1320–1323. doi: 10.1016/s0140-6736(65)92342-1. [DOI] [PubMed] [Google Scholar]
  19. WATSON D. A simple method for the determination of serum cholesterol. Clin Chim Acta. 1960 Sep;5:637–643. doi: 10.1016/0009-8981(60)90004-8. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES